Oracle Corporation $ORCL Position Lessened by Tiemann Investment Advisors LLC

Tiemann Investment Advisors LLC decreased its position in shares of Oracle Corporation (NYSE:ORCLFree Report) by 21.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 28,365 shares of the enterprise software provider’s stock after selling 7,666 shares during the period. Oracle makes up approximately 2.5% of Tiemann Investment Advisors LLC’s holdings, making the stock its 9th largest holding. Tiemann Investment Advisors LLC’s holdings in Oracle were worth $6,201,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. LGT Financial Advisors LLC purchased a new stake in Oracle in the second quarter worth about $33,000. Legend Financial Advisors Inc. bought a new position in shares of Oracle during the 2nd quarter valued at $34,000. HighMark Wealth Management LLC purchased a new position in Oracle in the second quarter worth about $38,000. Moser Wealth Advisors LLC increased its stake in shares of Oracle by 1,770.0% in the 2nd quarter. Moser Wealth Advisors LLC now owns 187 shares of the enterprise software provider’s stock worth $41,000 after purchasing an additional 177 shares in the last quarter. Finally, Orion Capital Management LLC raised its stake in shares of Oracle by 32.2% in the second quarter. Orion Capital Management LLC now owns 193 shares of the enterprise software provider’s stock worth $42,000 after buying an additional 47 shares during the period. 42.44% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CEO Clayton M. Magouyrk sold 40,000 shares of Oracle stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $276.64, for a total transaction of $11,065,600.00. Following the sale, the chief executive officer directly owned 154,030 shares in the company, valued at $42,610,859.20. This trade represents a 20.62% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Naomi O. Seligman sold 2,222 shares of the stock in a transaction dated Friday, September 26th. The stock was sold at an average price of $288.91, for a total transaction of $641,958.02. Following the sale, the director owned 29,225 shares of the company’s stock, valued at $8,443,394.75. This trade represents a 7.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 204,254 shares of company stock valued at $60,227,807 over the last 90 days. Insiders own 40.90% of the company’s stock.

Analyst Ratings Changes

ORCL has been the subject of a number of research analyst reports. Guggenheim increased their price objective on shares of Oracle from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, October 17th. Wolfe Research lifted their price objective on shares of Oracle from $300.00 to $400.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 10th. Barclays boosted their price objective on Oracle from $367.00 to $400.00 and gave the company an “overweight” rating in a report on Friday, October 17th. Stifel Nicolaus raised their target price on shares of Oracle from $250.00 to $350.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Finally, Weiss Ratings raised shares of Oracle from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday. Three analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $323.69.

Check Out Our Latest Research Report on ORCL

Oracle Stock Performance

NYSE ORCL opened at $241.02 on Tuesday. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $345.72. The company has a market cap of $687.10 billion, a PE ratio of 55.79, a price-to-earnings-growth ratio of 2.96 and a beta of 1.51. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The stock’s 50 day simple moving average is $279.62 and its 200-day simple moving average is $232.02.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. During the same quarter in the previous year, the company posted $1.39 earnings per share. The company’s revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, equities research analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th were paid a $0.50 dividend. The ex-dividend date was Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 0.8%. Oracle’s dividend payout ratio (DPR) is currently 46.30%.

About Oracle

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

See Also

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.